Decreased levels of elafin in the lungs of patients with acute lung injury as a result of proteolytic cleavage by the proteasome Source: Annual Congress 2012 - Mechanistic studies in airway cell biology Year: 2012
Differences in serum levels of inflammatory markers, proteases and antiproteases in COPD patients with and without emphysema Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
Alveolar extracellular 20S proteasome in patients with acute respiratory distress syndrome Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008
The proteasome - an intracellular protease that is dysregulated in lung diseases Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018
Serum leptin levels in patients with chronic airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005
Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation Source: Eur Respir J 2003; 22: 739-742 Year: 2003
Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients Source: Eur Respir J 2015; 45: 1482-1485 Year: 2015
Proteolytic activity of sputum and serum in patients with COPD exacerbation in dependence on smoking Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003
Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016
The role of serum cathepsin S levels in sarcoidosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Elevated serum S100A4 levels in patients with silicosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
Leptin, adiponectin and ghrelin levels in female patients with asthma during stable and exacerbation periods Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012
Can plasma arginase levels differantiate asthma and COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007
Asthmatics with high levels of serum surfactant protein D have more severe disease Source: Eur Respir J 2016; 47:1864-1867 Year: 2016
Serum levels of IL-6 in adult patients with moderate to severe asthma. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017
Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Evaluation of serum levels of Sirtuin-1 in lung cancer patients Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
Serum IL-17 and IL-18 levels in asthma-COPD overlap syndrome patients Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015